OTC/DTC Infectious Disease Diagnostics Research Report 2024: Strategies and Trends for OTC and DTC - Market Analysis, Executive Guides, and Market Opportunity Analysis 2023-2027
05 févr. 2024 04h12 HE
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics: Strategies and Trends for Over the Counter and Direct To Consumer - Forecasts by Application by Channel and by...
OTC/DTC Infectious Disease Diagnostics Global Market Report 2023: Benefits of Privacy and Anonymity Drive Growth
09 mars 2023 05h15 HE
|
Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Forecasts by Application by Channel by...
Enteric Disease Testing Global Market Report 2022: Sector to Reach $4.8 Billion by 2027 at a CAGR of 3.52%
02 févr. 2023 14h03 HE
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Syndromic Multiplex Panels Global Market Report 2023: Lower Costs and Point of Care Advantage Drives Adoption
16 janv. 2023 07h18 HE
|
Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country....
Global COVID-19 Diagnostic Demand Outlook Report 2021 with Focus on Molecular and Serology Testing
26 août 2021 09h28 HE
|
Research and Markets
Dublin, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Global Diagnostic Demand Outlook Report" report has been added to ResearchAndMarkets.com's offering. Can diagnostics stop an epidemic? Rapid...
Global Coronavirus (COVID-19) Vaccine Market Research Report 2021: Market is Expected to Grow at a Robust Rate to Reach $91.3 Billion
30 juil. 2021 05h53 HE
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type, By Product Type, By Route of Administration, By...
Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement
19 janv. 2021 08h00 HE
|
Cocrystal Pharma, Inc.
Program advances within the agreement’s initial two-year timeframe BOTHELL, Wash., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a...
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
20 avr. 2020 08h05 HE
|
Cocrystal Pharma, Inc.
- Work completed over decades of renowned biochemist’s career serves as basis for Company’s structure-based technology which has demonstrated broad utility in development of proprietary antivirals - ...